Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: Long-term results over a 10-year period

International Journal of Cancer

Volumn 134, Issue 5, 2014, Pages 1225-1231

  Gruber Rouh, Tatjana ^a   Naguib, Nagy N N ^a,b   Eichler, Katrin ^a   Ackermann, Hanns ^a   Zangos, Stephan ^a   Trojan, Jörg ^a   Beeres, Martin ^a   Harth, Marc ^a   Schulz, Boris ^a   Nour Eldin A , Nour Eldin ^a,b   Vogl, Thomas J ^a  

^a GOETHE UNIVERSITY   (Germany)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

chemoembolization; colorectal cancer; liver metastases

Indexed keywords

CISPLATIN; GEMCITABINE; IODINATED POPPYSEED OIL; IRINOTECAN; MEDAC; MICROSPHERE; MITOMYCIN; STARCH; TEVA; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FEVER; HUMAN; INOPERABLE CANCER; LIVER METASTASIS; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINIMALLY INVASIVE PROCEDURE; MORBIDITY; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL TIME; TUMOR LOCALIZATION; TUMOR VOLUME; VOMITING;

CHEMOEMBOLIZATION; COLORECTAL CANCER; LIVER METASTASES;

ADULT; AGED; CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84890562944     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28443     Document Type: Article

References (35)

1. Kemeny N,. Presurgical chemotherapy in patients being considered for liver resection. Oncologist 2007; 12: 825-39.
2. Vogl TJ, Zangos S, Balzer JO, et al. Transarterielle Chemoembolisation von Lebermetastasen: Indikationsstellung, Technik, Ergebnisse. Fortschr Röntgenstr 2002; 174: 675-83.
3. Wagner JS, Adson MA, Van Heerden JA, et al. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 1984; 199: 502-8.
4. Yan TD, Padang R, Morris DL,. Long-term results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: long-term survival can be achieved in patients with multiple bilateral liver metastases. J Am Coll Surg 2006; 202: 100-11.
5. Baker ME, Pelley R,. Hepatic metastases: basic principles and implications for radiologists. Radiology 1995; 197: 329-37.
6. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235: 759-66.
7. Brouquet A, Mortenson MM, Vauthey JN, et al. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 2010; 210: 934-41.
8. Brouquet A, Abdalla EK, Kopetz S, et al. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 2011; 29: 1083-90.
9. Giacchetti S, Itzhaki M, Gruia G, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999; 10: 663-9.
10. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004; 240: 644-57; discussion 657-8.
11. Tournigand C, André T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004; 22: 229-37.
12. Prenen H, Van Cutsem E,. Oncological management of unresectable liver metastases. Dig Dis 2012; 30 (Suppl 2): 137-42.
13. Konopke R, Roth J, Volk A, et al. Colorectal liver metastases: an update on palliative treatment options. J Gastrointestin Liver Dis 2012; 21: 83-91.
14. Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000; 355: 1041-7.
15. de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-47.
16. Tournigand C, André T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004; 22: 229-37.
17. Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000; 343: 905-14.
18. Welch S, Spithoff K, Rumble RB, et al.; Gastrointestinal Cancer Disease Site Group. Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review. Ann Oncol 2010; 21: 1152-62.
19. Kabbinavar F, Hurwitz HI, Fehrenbacher L, et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol 2003; 21: 60-5.
20. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-42.
21. Saltz LB, Clarke S, Díaz-Rubio E, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 2008; 26: 2013-19.
22. Brown DB, Geschwind JF, Soulen MC, et al. Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies. J Vasc Interv Radiol 2006; 17 (2 Part 1): 217-23.
23. Bavisotto LM, Patel NH, Althaus SJ, et al. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase 2 trial of the Puget Sound Oncology Concortium (PSOC 1104). Clin Cancer Res 1999; 5: 95-109.
24. Germer CT, Buhr HJ, Isbert C,. Nichtoperative Ablation Möglichkeiten und Grenzen der Ablationsverfahren zur Behandlung von Lebermetastasen unter kurativer Intention. Chirurg 2005; 76: 552-4, 556-63.
25. Kennedy A, Nag S, Salem R, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 2007; 68: 13-23.
26. Poggi G, Quaretti P, Minoia C, et al. Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors. Anticancer Res 2008; 28: 3835-42.
27. Mulcahy MF, Lewandowski RJ, Ibrahim SM, et al. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer 2009; 115: 1849-58.
28. Hong K, McBride JD, Georgiades CS, et al. Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. J Vasc Interv Radiol 2009; 20: 360-7.
29. Vogl TJ, Mack MG, Eichler K, et al. Chemoperfusion und -embolisation von Lebermetastasen. Fortschr Röntgenstr 2011; 183: 12-23.
30. Vogl TJ, Gruber T, Balzer JO, et al. Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study. Radiology 2009; 250: 281-9.
31. Lang EK, Brown CL, Jr,. Colorectal metastases to the liver: selective chemoembolization. Radiology 1993; 189: 417-22.
32. Clark TW,. Chemoembolization for colorectal liver metastases after FOLFOX failure. J Vasc Interv Radiol 2013; 24: 66-7.
33. Nordlinger B, Rougier P,. Liver metastases from colorectal cancer: the turning point. J Clin Oncol 2002; 20: 1442-5.
34. Wasser K, Giebel F, Fischbach R, et al. [Transarterial chemoembolization of liver metastases of colorectal carcinoma using degradable starch microspheres (Spherex): personal investigations and review of the literature]. Radiologe 2005; 45: 633-43.
35. Albert M, Kiefer MV, Sun W, et al. Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol. Cancer 2011; 117: 343-52.